Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Extend Biosciences in September, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK107231-04 | Phase II | 1,000,000 | September 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in September, 2019 for $535,325.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS115312-01 | Phase I | 535,325 | September 30, 2019 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in March, 2020 for $161,589.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-20-P-0038 | Phase I | 161,589 | March 12, 2020 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in September, 2015 for $306,738.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK107231-01A1 | Phase I | 306,738 | September 24, 2015 | |||||||
A SBIR Phase II contract was awarded to Extend Biosciences in May, 2015 for $999,998.0 USD from the U.S. Department of Defense. | SBIR | W911NF-14-C-0071 | Phase II | 999,998 | May 21, 2015 | |||||||
A SBIR Phase II contract was awarded to Extend Biosciences in April, 2017 for $2,212,084.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA213844-01 | Phase II | 2,212,084 | April 24, 2017 | |||||||
A SBIR Phase II contract was awarded to Extend Biosciences in September, 2017 for $3,730,799.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK107231-02A1 | Phase II | 3,730,799 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in September, 2017 for $350,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK115279-01 | Phase I | 350,000 | September 6, 2017 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in March, 2017 for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI131906-01 | Phase I | 600,000 | March 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in March, 2013 for $99,999.0 USD from the U.S. Department of Defense. | SBIR | W911NF-13-C-0033 | Phase I | 99,999 | March 25, 2013 | |||||||
A SBIR Phase II contract was awarded to Extend Biosciences in November, 2014 for $741,634.0 USD from the National Science Foundation. | SBIR | 1430894 | Phase II | 741,634 | November 10, 2014 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences in January, 2013 for $150,000.0 USD from the National Science Foundation. | SBIR | 1248500 | Phase I | 150,000 | January 1, 2013 | |||||||
A SBIR Phase I contract was awarded to Extend Biosciences for $288,302.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA174094-01A1 | Phase I | 288,302 | ||||||||
A SBIR Phase I contract was awarded to Extend Biosciences for $449,649.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA022547-01 | Phase I | 449,649 |